Get started
Author

Willem Delabie

Observed name: W. Delabie
Observed institution: Rode Kruis-Vlaanderen
ORCID: 0000-0003-4609-4842
Observed ORCID: 0000-0003-4609-4842
OpenAlex ID: A5086699390
Comparison between manufacturing sites shows differential adhesion, activation, and GPIbα expression of cryopreserved platelets
2018 · Katrijn R. Six, Willem Delabie, et al. · Transfusion · 46
PDF
Human platelet lysate standardization across three independent European blood establishments
2025 · Willem Delabie, Gabriele Boretti, et al. · Stem Cell Research & Therapy · 13
PDF
The senotherapeutic nicotinamide riboside raises platelet nicotinamide adenine dinucleotide levels but cannot prevent storage lesion
2019 · Willem Delabie, Wim Maes, et al. · Transfusion · 12
PDF
Single step method for high yield human platelet lysate production
2022 · Willem Delabie, Dominique De Bleser, et al. · Transfusion · 11
PDF
Towards standardized human platelet lysate production in Europe: An initiative of the European Blood Alliance
2023 · Dirk De Korte, Willem Delabie, et al. · Vox Sanguinis · 10
PDF
Comparison of culture media supplements identifies serum components in self-reported serum-free preparations
2025 · Willem Delabie, Vicky Vandewalle, et al. · Stem Cell Research & Therapy · 3
PDF
The (non-)necessity of Weaning Hek293 Cells From Fetal Bovine Serum to Human Platelet Lysate
2026 · W. Delabie, V. Vandewalle, et al. · Cytotherapy · 1
The Impact of Amotosalen Photochemical Pathogen Inactivation on Human Platelet Lysate
2024 · Willem Delabie, Dominique De Bleser, et al. · Current Stem Cell Research & Therapy · 1
PDF
Effective Culture of T-cells in Human Platelet Lysate While Maintaining Phenotype
2026 · W. Delabie, L. Cools, et al. · Cytotherapy
Testing Batch to Batch Variability of Human Platelet Lysate as a Medium Supplement for Gmp-compatible Skeletal Cell Culture
2026 · M. Marechal, C. Geeroms, et al. · Cytotherapy
Long-term Stability of Human Platelet Lysate at Different Temperatures
2026 · W. Delabie, V. Vandewalle, et al. · Cytotherapy
Process Development and Manufacturing: PATHOGEN INACTIVATED HUMAN PLATELET LYSATE AS A RELIABLE CELL CULTURE SUPPLEMENT
2023 · W. Delabie, V. Compernolle, et al. · Cytotherapy
Works count: 12
Citation count: 97
H-index: 5
I10-index: 5
Year
Topic
Type